Search research articles
Contact Us
Filters
Showing results (71-80 of 198) with videos related to
Page
of 20
Sort By:
Neuro-Oncology Advances
|
November 25, 2020
Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma
Sirui Ma, Soumon Rudra, Jian L Campian, et al.
Brain Tumor Pathology
|
March 11, 2016
High incidence of TERT mutation in brain tumor cell lines
Tanner M Johanns, Yujie Fu, Dale K Kobayashi, et al.
Science (New York, N.Y.)
|
November 11, 2009
A Cdc20-APC ubiquitin signaling pathway regulates presynaptic differentiation
Yue Yang, Albert H Kim, Tomoko Yamada, et al.
Experimental and Molecular Pathology
|
October 15, 2018
Analysis of point mutations and copy number variation in Grade II and III meningioma
Samantha N McNulty, Katherine Schwetye, Michael Goldstein, et al.
Journal of Neuro-Oncology
|
March 12, 2016
A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy
Jiayi Huang, Jian L Campian, Amit D Gujar, et al.
Scientific Reports
|
August 13, 2016
Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity
Yanchun Pan, Takuji Daito, Yo Sasaki, et al.
Scientific Reports
|
September 22, 2016
Erratum: Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity
Yanchun Pan, Takuji Daito, Yo Sasaki, et al.
Plos One
|
February 25, 2016
Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier
Eric C Leuthardt, Chong Duan, Michael J Kim, et al.
Stereotactic and Functional Neurosurgery
|
January 18, 2018
MRI-Guided Interstitial Laser Ablation for Intracranial Lesions: A Large Single-Institution Experience of 133 Cases
Ashwin A Kamath, Daniel D Friedman, Carl D Hacker, et al.
Journal of Neuro-Oncology
|
January 29, 2018
Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma
Jiayi Huang, Jian L Campian, Amit D Gujar, et al.
Page
of 20
Search research articles
Search
Showing results (71-80 of 198) with videos related to
Sort By:
Page
of 20
Neuro-Oncology Advances
|
November 25, 2020
Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma
Sirui Ma, Soumon Rudra, Jian L Campian, et al.
Brain Tumor Pathology
|
March 11, 2016
High incidence of TERT mutation in brain tumor cell lines
Tanner M Johanns, Yujie Fu, Dale K Kobayashi, et al.
Science (New York, N.Y.)
|
November 11, 2009
A Cdc20-APC ubiquitin signaling pathway regulates presynaptic differentiation
Yue Yang, Albert H Kim, Tomoko Yamada, et al.
Experimental and Molecular Pathology
|
October 15, 2018
Analysis of point mutations and copy number variation in Grade II and III meningioma
Samantha N McNulty, Katherine Schwetye, Michael Goldstein, et al.
Journal of Neuro-Oncology
|
March 12, 2016
A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy
Jiayi Huang, Jian L Campian, Amit D Gujar, et al.
Scientific Reports
|
August 13, 2016
Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity
Yanchun Pan, Takuji Daito, Yo Sasaki, et al.
Scientific Reports
|
September 22, 2016
Erratum: Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity
Yanchun Pan, Takuji Daito, Yo Sasaki, et al.
Plos One
|
February 25, 2016
Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier
Eric C Leuthardt, Chong Duan, Michael J Kim, et al.
Stereotactic and Functional Neurosurgery
|
January 18, 2018
MRI-Guided Interstitial Laser Ablation for Intracranial Lesions: A Large Single-Institution Experience of 133 Cases
Ashwin A Kamath, Daniel D Friedman, Carl D Hacker, et al.
Journal of Neuro-Oncology
|
January 29, 2018
Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma
Jiayi Huang, Jian L Campian, Amit D Gujar, et al.
Page
of 20